Pregnancy Related Clinical Trial
— EleVATE GCOfficial title:
Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care
Verified date | May 2024 |
Source | Washington University School of Medicine |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
This study will provide high-quality, representative data on the capacity of Elevating Voices, Addressing Depression, Toxic Stress and Equity in Group Prenatal Care (EleVATE GC) to reduce perinatal depression, preterm birth, and low birthweight in African-American women. If findings from this study indicate that EleVATE GC is feasible and effective, this model could be implemented nationwide to help achieve mental and obstetric health parity for low-income women of color in the United States.
Status | Enrolling by invitation |
Enrollment | 390 |
Est. completion date | June 30, 2025 |
Est. primary completion date | June 30, 2025 |
Accepts healthy volunteers | No |
Gender | Female |
Age group | 13 Years and older |
Eligibility | Inclusion Criteria: - English or Spanish speaking - =18 weeks' gestation - Established prenatal care at EleVATE site - High-risk for postpartum depression by =1 risk factor (personal/family history, baseline EPDS=10, low-income, 13-19 years old, single, history of physical/sexual abuse, unplanned/undesired pregnancy, history of pregnancy loss) - Ability to attend group prenatal visits at specified days/times - Willingness to be randomized - Ability to give informed consent - Any patient that has received prenatal care in a group setting previously Exclusion Criteria: - Multiple gestation - Major fetal anomaly - Serious medical co-morbidity/psychiatric illness necessitating more care than can be safely provided in group setting - Serious medical co-morbidity necessitating more care than can be safely provided in group setting |
Country | Name | City | State |
---|---|---|---|
United States | University of Missouri-Kansas City/Truman Health Centers-Kansas City | Kansas City | Missouri |
United States | Affinia Healthcare | Saint Louis | Missouri |
United States | CareSTL Health | Saint Louis | Missouri |
United States | Family Care Health Centers | Saint Louis | Missouri |
Lead Sponsor | Collaborator |
---|---|
Washington University School of Medicine |
United States,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | Perinatal Depression | Major Depression (Edinburgh Postnatal Depression Scale Score, range: 0-30, higher scores are a worse outcome) | Baseline visit | |
Primary | Perinatal Depression | Major Depression (Edinburgh Postnatal Depression Scale Score, range: 0-30, higher scores are a worse outcome) | 28-40 week visit | |
Primary | Perinatal Depression | Major Depression (Edinburgh Postnatal Depression Scale Score, range: 0-30, higher scores are a worse outcome) | 4-12 weeks Postpartum | |
Secondary | Preterm Birth | Delivery at <37 weeks gestation | Delivery | |
Secondary | Small for Gestational Age | Birthweight <10th percentile on the Alexander growth curve | Delivery | |
Secondary | Perceived Stress | Perceived Stress Scale Total Scores, range: 0-40, higher scores are a worse outcome | Baseline visit | |
Secondary | Perceived Stress | Perceived Stress Scale Total Scores, range: 0-40, higher scores are a worse outcome | 28-40 week | |
Secondary | Perceived Stress | Perceived Stress Scale Total Scores, range: 0-40, higher scores are a worse outcome | 4-12 weeks Postpartum | |
Secondary | Anxiety | PROMIS Short Form Anxiety 8a T-Score, range: 37.1-83.1, higher scores are a worse outcome | Baseline visit | |
Secondary | Anxiety | PROMIS Short Form Anxiety 8a T-Score, range: 37.1-83.1, higher scores are a worse outcome | 28-40 week visit | |
Secondary | Anxiety | PROMIS Short Form Anxiety 8a T-Score, range: 37.1-83.1, higher scores are a worse outcome | 4-12 weeks Postpartum | |
Secondary | Post-Traumatic Stress Disorder (PTSD) | PTSD Checklist for DSM-V Total Symptom Severity Score, range 0-80, higher scores are a worse outcome | Baseline Visit | |
Secondary | Social Support | PROMIS Bank 2.0 Social Support (emotional support, instrumental support, informational support, and social isolation domains) T-Scores, range 23.7-76.9, higher scores are better outcomes for emotional support, instrumental support and informational support, higher scores are worse outcomes for social isolation | Baseline visit | |
Secondary | Social Support | PROMIS Bank 2.0 Social Support (emotional support, instrumental support, informational support, and social isolation domains) T-Scores, range 23.7-76.9, higher scores are better outcomes for emotional support, instrumental support and informational support, higher scores are worse outcomes for social isolation | 28-40 week visit | |
Secondary | Social Support | PROMIS Bank 2.0 Social Support (emotional support, instrumental support, informational support, and social isolation domains) T-Scores, range 23.7-76.9, higher scores are better outcomes for emotional support, instrumental support and informational support, higher scores are worse outcomes for social isolation | 4-12 weeks Postpartum | |
Secondary | Race-Related Stress | Index of Race Related Stress-Brief Version Total Score, range 0-22, higher scores are worse outcomes | Baseline visit | |
Secondary | Maternal Attachment (Antenatal) | Maternal Antenatal Attachment Scale Total Score, range 19-95, higher scores are better outcomes | Baseline visit | |
Secondary | Maternal Attachment (Antenatal) | Maternal Antenatal Attachment Scale Total Score, range 19-95, higher scores are better outcomes | 28-40 week visit | |
Secondary | Maternal Attachment (Postnatal) | Maternal Postnatal Attachment Scale Total Score, range 19-95, higher scores are better outcomes | 4-12 Weeks Postpartum |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT05017974 -
Research on Improving Sleep During Pregnancy
|
N/A | |
Completed |
NCT03284515 -
Vaccination In Pregnancy Gene Signature: VIP Signature Study
|
||
Recruiting |
NCT05969795 -
Comparison of Live Birth Rate in Natural Cycle Single Euploid FET Versus Without Luteal Phase Support
|
Phase 1 | |
Recruiting |
NCT06051201 -
Innovation for Small-scale Experiments: ReceptIVFity Test
|
N/A | |
Recruiting |
NCT04828382 -
Prospective Study of Pregnancy in Women With Cystic Fibrosis
|
||
Enrolling by invitation |
NCT04527926 -
STEPuP: Prenatal Provider Education and Training to Improve Medication-assisted Treatment Use During Pregnancy
|
N/A | |
Recruiting |
NCT04278651 -
Early Antenatal Support for Iron Deficiency Anemia
|
Phase 4 | |
Recruiting |
NCT04405700 -
Measuring Adverse Pregnancy and Newborn Congenital Outcomes
|
||
Recruiting |
NCT06258902 -
Odevixibat Pregnancy and Lactation Surveillance Program: A Study to Evaluate the Safety of Odevixibat During Pregnancy and/or Lactation
|
||
Completed |
NCT05487196 -
Effectiveness of Clonidine, Dexmedetomidine, and Fentanyl Adjuncts for Labor Epidural Analgesia
|
Phase 2 | |
Completed |
NCT03750968 -
Lutein & Zeaxanthin in Pregnancy - Carotenoid Supplementation During Pregnancy: Ocular and Systemic Effects
|
Phase 2 | |
Enrolling by invitation |
NCT06127277 -
Next4You: A Fully Mobile Relationships Based Program for Youth in Foster Care
|
N/A | |
Completed |
NCT05897697 -
Assessing Women's Preferences for Postpartum Thromboprophylaxis: the Prefer-Postpartum Study
|
||
Recruiting |
NCT05899101 -
The Impact of Opioid and Cannabis Exposure on Fetal Growth
|
||
Completed |
NCT05502510 -
Assessing the Effectiveness and Efficacy of the MyHealthyPregnancy Application
|
||
Completed |
NCT04296396 -
Opioid Prescription After Cesarean Trial
|
Phase 3 | |
Not yet recruiting |
NCT06069856 -
Multiple Micronutrient Supplementation (MMS) IFA- Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT06069869 -
Multiple Micronutrient Supplementation (MMS) Iron Dose Acceptability Crossover Trial
|
Phase 3 | |
Not yet recruiting |
NCT06079918 -
Multiple Micronutrient Supplementation for Maternal Anemia Prevention in Tanzania
|
Phase 3 | |
Not yet recruiting |
NCT06163651 -
Evaluating a One-Year Version of the Parent-Child Assistance Program
|
N/A |